Name: Startup Pitch Presentations: Oncology
Start: 2026-09-29T12:15:00+0200
End: 2026-09-29T13:15:00+0200

Tuesday September 29, 2026 12:15 - 13:15 CEST

Companies seeking funding to develop treatments in neurology and oncology will present their companies and pitch their business opportunity.

Attendees will be invited to vote for the best start up pitch presentation. The winner will get a free registration to BIOSPAIN 2027.

Ability Pharmaceuticals, SA – Carles Domènech, CEO
Innoup Farma Kinsy, S.l. – Elisa Longás, Chief Business Officer
Labsinlove S.L. - Cristina Aguilera, CEO
Lifesome Therapeutics, S.L. – Ana Bouchet, CEO
MIMO BIOSCIENCES – Jessika Valero Gonzalez,. Business Development Director
Nuage Therapeutics – Andri Leonidou, Head Of Bi And Corporate Affairs
Oncomatryx Biopharma SA – Teresa Rodriguez-Carmona Garcia, Business Development Associate
Peptomyc, S.l. – Jesús Martín García, CEO
Trimerbody Pharma – Marta Compte Grau, R&D Director

Speakers

Carles Domènech

CEO, Ability Pharma, S.A.

Carles Domènech, PhD, is Executive Chairman, CEO and co-founder of AbilityPharma, with 30+ years of international experience in biotech, pharma business development, licensing and venture capital. He holds a Biology degree and PhD from Universitat Autònoma de Barcelona, plus business... Read More →

Elisa Longás

Chief Business Officer, Innoup Pharma

Elisa Longás is Chief Business Officer at InnoUp Farma, where she leads corporate strategy, business development and global partnering initiatives. She combines scientific and biotech & pharmaceutical business expertise to drive strategic growth opportunities and international collaborations... Read More →

Cristina Aguilera

CEO, Labsinlove

Cristina Aguilera Xiol, PhD MBM, is CEO of Labsinlove and has an international background in biotechnology, translational medicine and innovation management. She started her career in academia as a researcher and later worked internationally across both academia and industry, including... Read More →

Ana Bouchet

CEO, Lifesome Therapeutics, S.L.

Ana Bouchet is the Co-founder and CEO of Lifesome Therapeutics. She holds a degree in Biotechnology and a PhD in Lipid Biophysics. Her research interests include nanotechnology, molecular delivery, and biophysics applied to biomaterials. In 2022, she spearheaded the company’s growth... Read More →

Jessika Valero Gonzalez

Business Director, Mimo Biosciences

Jessika Valero González, PhD, leads Business Development and Strategy at MIMO Biosciences, where she drives growth, strategic partnerships, and market expansion. With extensive experience in biotechnology innovation and commercialization, she focuses on connecting breakthrough science... Read More →

Andri Leonidou

Head Of Bi And Corporate Affairs, Nuage Therapeutics

Andri Leonidou is Head of Business Intelligence and Corporate Affairs at Nuage Therapeutics, responsible for competitive intelligence, partnership assessments, and strategic insights to support the company's pipeline and business development activities. She holds a PhD in breast cancer... Read More →

Teresa Rodríguez-Carmona García

Business Development Associate, Oncomatryx Biopharma SA

Teresa is a business development associate at Oncomatryx Biopharma S.A. since October 2025. She supports BD activities by contributing to strategic partnerships, market analysis and stakeholder engagement for preclincial and clinical programs. Teresa holds a Bsc (Honours) in Biomedical... Read More →

Jesús Martin Garcia

CEO, Peptomyc, S.L.

Jesús Martín García is CEO of Peptomyc, with over two decades of leadership in drug development, biotech strategy and corporate finance. He has held CEO and Board roles, leading clinical-stage programs, partnering transactions and capital raises from Series A through IPO. He holds... Read More →

Marta Compte Grau

R&D Director, Trimerbody Pharma

Marta Compte Grau MD, PhD Immunologist and biotech executive with more than 15 years of experience in immuno-oncology, antibody engineering and translational development of biologics. Currently leading scientific, operational and strategic activities at Trimerbody Pharma, advancing... Read More →

Tuesday September 29, 2026 12:15 - 13:15 CEST
4 Raúl Martín room

Startup pitch presentations

Audience English language
Track Finance & investment

BIOSPAIN 2026